Solid 1Q09 Results from Grifols
Revenues jumped +16.8% to €235.6m, bolstered by the strength of the Bioscience division.
Bioscience keeps bearing the group’s growth in absolute terms, with sales growing +15.0% YoY to €175.3m. Growth was based on volume, and, according to the company, prices have kept a stable trend, as expected. The amount of fractionated plasma reached new maximums, although [...]
